Special Issue "Pathology of Gynecologic Cancer"
Deadline for manuscript submissions: 5 September 2024 | Viewed by 2930
Interests: gynecological pathology; breast pathology; cytology; infectious pathology
Interests: gestational trophoblastic disease; cancer in pregnancy; rare gynaecologic cancers and development and treatment of ovarian cancer
Cancer is one of the most fatal diseases globally, and gynecologic-associated cancers are a huge burden on families and society that affect women of reproductive age in the modern world. In the meantime, it is necessary to quickly develop effective screening methods, diagnoses, and proper treatment as well as care strategies to preserve the fertility of women with gynecologic cancer.
New biomarkers are not only prognostic and predictive, but often have an extended diagnostic use as well. This Special Issue wants to address biomarkers in both tumors and their microenvironments, detected by either routine immunohistochemical tools or by the innovative implementation of artificial intelligence and machine learning in pathology diagnoses. The identification of these novel biomarkers and techniques enables the pathologist to play an active role in multidisciplinary decision making to support gynecological oncologists in choosing the best treatments for their patients.
The aim of this Special Issue is to focus on publishing high-quality works that are related to the pathology of gynecologic oncology and its diagnosis, treatment, care, and related diagnostic as well as therapeutic strategies.
Prof. Dr. Koen K.B.T. Van de Vijver
Dr. Christianne Lok
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gynecologic cancer
- artificial intelligence
- deep learning